1 Introduction to Research & Analysis Reports |
|
1.1 Ambroxol Market Definition |
|
1.2 Market Segments |
|
| 1.2.1 Segment by Type | |
| 1.2.2 Segment by Application | |
1.3 China Ambroxol Market Overview |
|
1.4 Methodology & Sources of Information |
|
| 1.4.1 Research Methodology | |
| 1.4.2 Research Process | |
| 1.4.3 Base Year | |
2 China Ambroxol Overall Market Size |
|
2.1 China Ambroxol Market Size: 2021 VS 2027 |
|
2.2 China Ambroxol Revenue, Prospects & Forecasts: 2016-2027 |
|
2.3 China Ambroxol Sales: 2016-2027 |
|
3 Company Landscape |
|
3.1 Top Ambroxol Players in China Market |
|
3.2 Top China Ambroxol Companies Ranked by Revenue |
|
3.3 China Ambroxol Revenue by Companies |
|
3.4 China Ambroxol Sales by Companies |
|
3.5 China Ambroxol Price by Manufacturer (2016-2021) |
|
3.6 Top 3 and Top 5 Ambroxol Companies in China Market, by Revenue in 2020 |
|
3.7 Manufacturers Ambroxol Product Type |
|
3.8 Tier 1, Tier 2 and Tier 3 Ambroxol Players in China Market |
|
| 3.8.1 List of Tier 1 Ambroxol Companies in China | |
| 3.8.2 List of Tier 2 and Tier 3 Ambroxol Companies in China | |
4 Sights by Type |
|
4.1 Overview |
|
| 4.1.1 By Type - China Ambroxol Market Size Markets, 2021 & 2027 | |
| 全文：http://www.qdlaimaiche.com/2/91/China-Ambroxol-Industry-In-Depth-Research-and-Market-Outlook-Report-2021-2027.html | |
| 4.1.2 Normal type | |
| 4.1.3 Long-acting type | |
4.2 By Type - China Ambroxol Revenue & Forecasts |
|
| 4.2.1 By Type - China Ambroxol Revenue, 2016-2021 | |
| 4.2.2 By Type - China Ambroxol Revenue, 2022-2027 | |
| 4.2.3 By Type - China Ambroxol Revenue Market Share, 2016-2027 | |
4.3 By Type - China Ambroxol Sales & Forecasts |
|
| 4.3.1 By Type - China Ambroxol Sales, 2016-2021 | |
| 4.3.2 By Type - China Ambroxol Sales, 2022-2027 | |
| 4.3.3 By Type - China Ambroxol Sales Market Share, 2016-2027 | |
4.4 By Type - China Ambroxol Price (Manufacturers Selling Prices), 2016-2027 |
|
5 Sights by Application |
|
5.1 Overview |
|
| 5.1.1 By Application - China Ambroxol Market Size, 2021 & 2027 | |
| 5.1.2 Acute Respiratory Diseases | |
| 5.1.3 Chronic Respiratory Diseases | |
5.2 By Application - China Ambroxol Revenue & Forecasts |
|
| 5.2.1 By Application - China Ambroxol Revenue, 2016-2021 | |
| 5.2.2 By Application - China Ambroxol Revenue, 2022-2027 | |
| 5.2.3 By Application - China Ambroxol Revenue Market Share, 2016-2027 | |
5.3 By Application - China Ambroxol Sales & Forecasts |
|
| 5.3.1 By Application - China Ambroxol Sales, 2016-2021 | |
| 5.3.2 By Application - China Ambroxol Sales, 2022-2027 | |
| 5.3.3 By Application - China Ambroxol Sales Market Share, 2016-2027 | |
5.4 By Application - China Ambroxol Price (Manufacturers Selling Prices), 2016-2027 |
|
6 Manufacturers & Brands Profiles |
|
6.1 Teva |
|
| 6.1.1 Teva Corporation Information | |
| 6.1.2 Teva Overview | |
| 6.1.3 Teva Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.1.4 Teva Ambroxol Product Description | |
| 6.1.5 Teva Recent Developments | |
6.2 Bayer |
|
| 6.2.1 Bayer Corporation Information | |
| 6.2.2 Bayer Overview | |
| 6.2.3 Bayer Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.2.4 Bayer Ambroxol Product Description | |
| 6.2.5 Bayer Recent Developments | |
6.3 Novartis |
|
| 6.3.1 Novartis Corporation Information | |
| 6.3.2 Novartis Overview | |
| 6.3.3 Novartis Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.3.4 Novartis Ambroxol Product Description | |
| 6.3.5 Novartis Recent Developments | |
6.4 Mylan |
|
| 6.4.1 Mylan Corporation Information | |
| 6.4.2 Mylan Overview | |
| 6.4.3 Mylan Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.4.4 Mylan Ambroxol Product Description | |
| 6.4.5 Mylan Recent Developments | |
6.5 Bidachem |
|
| 6.5.1 Bidachem Corporation Information | |
| 6.5.2 Bidachem Overview | |
| 6.5.3 Bidachem Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.5.4 Bidachem Ambroxol Product Description | |
| 6.5.5 Bidachem Recent Developments | |
6.6 Hanmi |
|
| 中國Ambroxol行業(yè)深入研究和市場前景2021-2027 | |
| 6.6.1 Hanmi Corporation Information | |
| 6.6.2 Hanmi Overview | |
| 6.6.3 Hanmi Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.6.4 Hanmi Ambroxol Product Description | |
| 6.6.5 Hanmi Recent Developments | |
6.7 Hexal Pharma |
|
| 6.7.1 Hexal Pharma Corporation Information | |
| 6.7.2 Hexal Pharma Overview | |
| 6.7.3 Hexal Pharma Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.7.4 Hexal Pharma Ambroxol Product Description | |
| 6.7.5 Hexal Pharma Recent Developments | |
6.8 Sris Pharmaceuticals |
|
| 6.8.1 Sris Pharmaceuticals Corporation Information | |
| 6.8.2 Sris Pharmaceuticals Overview | |
| 6.8.3 Sris Pharmaceuticals Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.8.4 Sris Pharmaceuticals Ambroxol Product Description | |
| 6.8.5 Sris Pharmaceuticals Recent Developments | |
6.9 Hubei Ocean Biotechnology |
|
| 6.9.1 Hubei Ocean Biotechnology Corporation Information | |
| 6.9.2 Hubei Ocean Biotechnology Overview | |
| 6.9.3 Hubei Ocean Biotechnology Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.9.4 Hubei Ocean Biotechnology Ambroxol Product Description | |
| 6.9.5 Hubei Ocean Biotechnology Recent Developments | |
6.10 DM Pharma |
|
| 6.10.1 DM Pharma Corporation Information | |
| 6.10.2 DM Pharma Overview | |
| 6.10.3 DM Pharma Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.10.4 DM Pharma Ambroxol Product Description | |
| 6.10.5 DM Pharma Recent Developments | |
6.11 Abbott |
|
| 6.11.1 Abbott Corporation Information | |
| 6.11.2 Abbott Overview | |
| 6.11.3 Abbott Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.11.4 Abbott Ambroxol Product Description | |
| 6.11.5 Abbott Recent Developments | |
6.12 Takeda |
|
| 6.12.1 Takeda Corporation Information | |
| 6.12.2 Takeda Overview | |
| 6.12.3 Takeda Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.12.4 Takeda Ambroxol Product Description | |
| 6.12.5 Takeda Recent Developments | |
6.13 Chemsol Lab |
|
| 6.13.1 Chemsol Lab Corporation Information | |
| 6.13.2 Chemsol Lab Overview | |
| 6.13.3 Chemsol Lab Ambroxol Sales and Revenue in China Market (2016-2021) | |
| 6.13.4 Chemsol Lab Ambroxol Product Description | |
| 6.13.5 Chemsol Lab Recent Developments | |
7 China Ambroxol Production Capacity, Analysis |
|
7.1 China Ambroxol Production Capacity, 2016-2027 |
|
7.2 Ambroxol Production Capacity of Key Manufacturers in China Market |
|
8 Key Market Trends, Opportunity, Drivers and Restraints |
|
8.1 Market Opportunities & Trends |
|
8.2 Market Drivers |
|
8.3 Market Restraints |
|
9 Ambroxol Supply Chain Analysis |
|
9.1 Ambroxol Industry Value Chain |
|
9.2 Ambroxol Upstream Market |
|
| 中國鹽酸氨溴索行業(yè)深入研究和市場展望報告2021年至2027年 | |
9.3 Ambroxol Downstream and Clients |
|
9.4 Marketing Channels Analysis |
|
| 9.4.1 Marketing Channels | |
| 9.4.2 Ambroxol Distributors and Sales Agents in China Market | |
10 Conclusion |
|
11 Appendix |
|
11.1 Note |
|
11.2 Examples of Clients |
|
11.3 Author Details |
|
11.4 Disclaimer |
|
| List of Tables | |
| Table 1. Key Players of Ambroxol in China Market | |
| Table 2. Top Ambroxol Players in China Market, Ranking by Revenue (2019) | |
| Table 3. China Ambroxol Revenue by Companies, (US$, Mn), 2016-2021 | |
| Table 4. China Ambroxol Revenue Share by Companies, 2016-2021 | |
| Table 5. China Ambroxol Sales by Companies, (K Pcs), 2016-2021 | |
| Table 6. China Ambroxol Sales Share by Companies, 2016-2021 | |
| Table 7. Key Manufacturers Ambroxol Price (2016-2021) & (USD/Pcs) | |
| Table 8. Manufacturers Ambroxol Product Type | |
| Table 9. List of Tier 1 Ambroxol Companies, Revenue (US$, Mn) in 2020 and Market Share | |
| Table 10. List of Tier 2 and Tier 3 Ambroxol Companies, Revenue (US$, Mn) in 2020 and Market Share | |
| Table 11. Major Manufacturers of Normal type | |
| Table 12. Major Manufacturers of Long-acting type | |
| Table 13. By Type – China Ambroxol Revenue, (US$, Mn), 2021 & 2027 | |
| Table 14. By Type - China Ambroxol Revenue (US$, Mn), 2016-2021 | |
| Table 15. By Type - China Ambroxol Revenue (US$, Mn), 2022-2027 | |
| Table 16. By Type - China Ambroxol Sales (K Pcs), 2016-2021 | |
| Table 17. By Type - China Ambroxol Sales (K Pcs), 2022-2027 | |
| Table 18. By Application – China Ambroxol Revenue, (US$, Mn), 2021 VS 2027 | |
| Table 19. By Application - China Ambroxol Revenue (US$, Mn), 2016-2021 | |
| Table 20. By Application - China Ambroxol Revenue (US$, Mn), 2022-2027 | |
| Table 21. By Application - China Ambroxol Sales (K Pcs), 2016-2021 | |
| Table 22. By Application - China Ambroxol Sales (K Pcs), 2022-2027 | |
| Table 23. Teva Corporation Information | |
| Table 24. Teva Description and Major Businesses | |
| Table 25. Teva Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 26. Teva Ambroxol Product | |
| Table 27. Teva Recent Developments | |
| Table 28. Bayer Corporation Information | |
| Table 29. Bayer Description and Major Businesses | |
| Table 30. Bayer Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 31. Bayer Ambroxol Product | |
| Table 32. Bayer Recent Developments | |
| Table 33. Novartis Corporation Information | |
| Table 34. Novartis Description and Major Businesses | |
| Table 35. Novartis Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 36. Novartis Ambroxol Product | |
| Table 37. Novartis Recent Developments | |
| Table 38. Mylan Corporation Information | |
| Table 39. Mylan Description and Major Businesses | |
| Table 40. Mylan Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 41. Mylan Ambroxol Product | |
| Table 42. Mylan Recent Developments | |
| Table 43. Bidachem Corporation Information | |
| Table 44. Bidachem Description and Major Businesses | |
| Table 45. Bidachem Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 46. Bidachem Ambroxol Product | |
| zhōngguó yánsuān ān xiù suǒ hángyè shēnrù yánjiū hé shìchǎng zhǎnwàng bàogào 2021 nián zhì 2027 nián | |
| Table 47. Bidachem Recent Developments | |
| Table 48. Hanmi Corporation Information | |
| Table 49. Hanmi Description and Major Businesses | |
| Table 50. Hanmi Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 51. Hanmi Ambroxol Product | |
| Table 52. Hanmi Recent Developments | |
| Table 53. Hexal Pharma Corporation Information | |
| Table 54. Hexal Pharma Description and Major Businesses | |
| Table 55. Hexal Pharma Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 56. Hexal Pharma Ambroxol Product | |
| Table 57. Hexal Pharma Recent Developments | |
| Table 58. Sris Pharmaceuticals Corporation Information | |
| Table 59. Sris Pharmaceuticals Description and Major Businesses | |
| Table 60. Sris Pharmaceuticals Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 61. Sris Pharmaceuticals Ambroxol Product | |
| Table 62. Sris Pharmaceuticals Recent Developments | |
| Table 63. Hubei Ocean Biotechnology Corporation Information | |
| Table 64. Hubei Ocean Biotechnology Description and Major Businesses | |
| Table 65. Hubei Ocean Biotechnology Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 66. Hubei Ocean Biotechnology Ambroxol Product | |
| Table 67. Hubei Ocean Biotechnology Recent Developments | |
| Table 68. DM Pharma Corporation Information | |
| Table 69. DM Pharma Description and Major Businesses | |
| Table 70. DM Pharma Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 71. DM Pharma Ambroxol Product | |
| Table 72. DM Pharma Recent Developments | |
| Table 73. Abbott Corporation Information | |
| Table 74. Abbott Description and Major Businesses | |
| Table 75. Abbott Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 76. Abbott Ambroxol Product | |
| Table 77. Abbott Recent Developments | |
| Table 78. Takeda Corporation Information | |
| Table 79. Takeda Description and Major Businesses | |
| Table 80. Takeda Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 81. Takeda Ambroxol Product | |
| Table 82. Takeda Recent Developments | |
| Table 83. Chemsol Lab Corporation Information | |
| Table 84. Chemsol Lab Description and Major Businesses | |
| Table 85. Chemsol Lab Ambroxol Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) | |
| Table 86. Chemsol Lab Ambroxol Product | |
| Table 87. Chemsol Lab Recent Developments | |
| Table 88. Ambroxol Production Capacity (K Pcs) of Key Manufacturers in China Market, 2019-2021 (K Pcs) | |
| Table 89. China Ambroxol Capacity Market Share of Key Manufacturers, 2019-2021 | |
| Table 90. Ambroxol Market Opportunities & Trends in China Market | |
| Table 91. Ambroxol Market Drivers in China Market | |
| Table 92. Ambroxol Market Restraints in China Market | |
| Table 93. Ambroxol Raw Materials | |
| Table 94. Ambroxol Raw Materials Suppliers in China Market | |
| Table 95. Typical Ambroxol Downstream | |
| Table 96. Ambroxol Downstream Clients in China Market | |
| Table 97. Ambroxol Distributors and Sales Agents in China Market | |
| List of Figures | |
| Figure 1. Ambroxol Product Picture | |
| Figure 2. Ambroxol Segment by Type | |
| Figure 3. Ambroxol Segment by Application | |
| Figure 4. China Ambroxol Market Overview: 2020 | |
| Figure 5. China Ambroxol Market Size: 2021 VS 2027 (US$, Mn) | |
| 中國Ambroxol Industryの詳細な研究と市場見通しの報告書2021-2027 | |
| Figure 6. China Ambroxol Revenue, 2016-2027 (US$, Mn) | |
| Figure 7. Ambroxol Sales in China Market: 2016-2027 (K Pcs) | |
| Figure 8. The Top 3 and 5 Players Market Share by Ambroxol Revenue in 2020 | |
| Figure 9. Normal type Product Picture | |
| Figure 10. Long-acting type Product Picture | |
| Figure 11. By Type - China Ambroxol Sales Market Share, 2016-2027 | |
| Figure 12. By Type - China Ambroxol Revenue Market Share, 2016-2027 | |
| Figure 13. By Type - China Ambroxol Price (USD/Pcs), 2016-2027 | |
| Figure 14. Acute Respiratory Diseases | |
| Figure 15. Chronic Respiratory Diseases | |
| Figure 16. By Application - China Ambroxol Sales Market Share, 2016-2027 | |
| Figure 17. By Application - China Ambroxol Revenue Market Share, 2016-2027 | |
| Figure 18. By Application - China Ambroxol Price (USD/Pcs), 2016-2027 | |
| Figure 19. Teva Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 20. Bayer Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 21. Novartis Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 22. Mylan Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 23. Bidachem Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 24. Hanmi Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 25. Hexal Pharma Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 26. Sris Pharmaceuticals Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 27. Hubei Ocean Biotechnology Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 28. DM Pharma Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 29. Abbott Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 30. Takeda Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 31. Chemsol Lab Ambroxol Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 32. China Ambroxol Production Capacity (K Pcs), 2016-2027 | |
| Figure 33. Ambroxol Industry Value Chain | |
| Figure 34. Marketing Channels | |
略……
如需購買《China Ambroxol Industry In-Depth Research and Market Outlook Report 2021-2027》，編號：3160912
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”
京公網(wǎng)安備 11010802027365號